CIS has once again been named to the Triangle Business Journal's Fast 50, an annual listing of the fastest-growing private companies in the Raleigh-Durham area.
SFL's Managing Director, Shayesteh Furst-Ladani will be giving presentations at two upcoming Swiss life science events on revision of EU Medtech legislation.
Pfizer as one of the global leading originators has extended operations with Media-Soft Pharmacentric Solutions. Pfizer has gone live with the global most flexible Bookvision CLM and Sales Vision CRM solution for pharmaceuticals.
CIS announced the launch of its Emergent BioPharma Insights™ commercial solutions for clinical stage companies at Pennsylvania Bio's Life Sciences Future 2013.
Asset Capital Management SA has announced completion of the annual certification for authorized regulatory organisation Standards Association for Quality Assurance in Financial Services.
The problem of dispensing multiple drugs for life-saving surgeries and on-going patient treatment has just become easier, quicker, more accurate and productive as a new technology is now available globally. LMM Global Innovations Inc has teamed with Global FranTech Group and its subdivision FranTech USA to market a newly patented multiple drug dispensing technology worldwide.
CIS will address the importance of vendor oversight by examining the CIS model for implementing a Vendor Oversight Capability in the complimentary webinar "Vendor Oversight - The Path Forward."
Compliance Implementation Services (CIS), a leading life sciences consulting firm, is a winner of the 2013 North Carolina Mid-Market FAST 40, an annual program developed by Cherry Bekaert LLP and presented by Business North Carolina. This list recognizes the state's top 20 Small-Middle Market companies with revenues of $15 million to $100 million and Large-Middle Market companies with revenues of $100 million to $500 million.
CIS announced that Clarissa Crain, Vice President, Consulting, will speak at the 8th Annual PharmaForce, taking place at the Westin Princeton at Forrestal Village today through Wednesday, October 23.
CIS has been named one of the fastest growing privately held companies again by the Philadelphia 100® and one of six companies inducted into the Philadelphia 100 Hall of Fame.
Calvert Research, LLC, a business unit of Calvert Holdings, Inc., and Oncoceutics, Inc. announced the execution of an Investment Partnership Agreement to support completion of preclinical studies for ONC201, Oncoceutics' experimental anti-cancer compound.
CIS' Tim Krzeminski, Director, Audit and Risk Assurance, and Madeline Heck, Project Manager, Audit and Risk Assurance, will speak at the 4th Annual Pharma/Biotech/Device Internal Audit Summit.
Paragon Laboratories is a leader in the contract supplement manufacturing business, and has been providing their clients with the highest standards for dietary supplements since 1971.
Neil DeHenes, formerly of Cardinal Health, joins CIS as Senior Director, Pre-Commercialization Services. Mr. DeHenes will provide consulting services and strategy development for commercialization functions related to sales, marketing and contracting for products distributed in the US market.
High purity tubing and single use systems manufacturer AdvantaPure will exhibit at several upcoming trade shows. The company's products are made for pharmaceutical, bioprocess and other clean uses. Events include the BioProcess International Conference in Boston; ILMAC in Basel, Switzerland; and China-Pharm in Shanghai. Other regional shows on the east coast of the U.S. will also be covered.
Innovus Pharmaceuticals, Inc., ("Innovus Pharma") www.innovuspharma.com (OTC: BB: INNV) announced today it has launched a newly designed corporate website.
CIS will offer Government Programs (GP) webinars over the summer months including lessons learned from Medicaid Managed Care Organizations (MMCO), 340B and Bona Fide Service Fees (BFSF).
Satisfied Users & 
Approved Press Releases
